Principles for constructing a tuberculosis treatment regimen: the role and definition of core and companion drugs

The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
A Van DeunH L Rieder

Abstract

Current World Health Organization guidelines for the formulation of treatment regimens for multidrug-resistant tuberculosis (MDR-TB) pay too little attention to the microbiological activity of anti-tuberculosis drugs. Here, we draw lessons from the pioneering work done on shorter MDR-TB treatment regimens and the current knowledge of the bactericidal and sterilizing properties of the drugs to inform the composition of treatment regimens for MDR-TB. We propose to reserve the term 'core drug' for the one drug in a regimen that contributes most to relapse-free cure. The core drug has both moderate to high bactericidal and sterilizing activity, is given throughout treatment, is well tolerated, and has no cross-resistance with the core drug used in the previous regimen. Currently used core drugs include rifampicin in the first-line 6-month regimen, and fourth-generation fluoroquinolones and bedaquiline in regimens for drug-resistant TB. All other drugs are 'companion drugs', used to avert treatment failure due to acquired drug resistance against the core drug. Some also help further reduce the risk of relapse. Moreover, toxic drugs should be avoided if there is an alternative. A regimen must always include the core drug, plus at lea...Continue Reading

Citations

Aug 4, 2018·Expert Review of Pharmacoeconomics & Outcomes Research·Ana-Maria IonescuAdrian Thomas
Jul 19, 2019·Journal of the International AIDS Society·Neesha RockwoodAnton L Pozniak
Aug 16, 2019·Journal of Clinical Microbiology·Kamela C S NgLeen Rigouts
Mar 5, 2020·American Journal of Respiratory and Critical Care Medicine·Tom DecrooArmand Van Deun
Dec 29, 2019·Journal of Clinical Medicine·Arnaud TrébucqValérie Schwoebel
Jun 21, 2020·Journal of Clinical Medicine·François CizaNimer Ortuño-Gutiérrez
Jul 4, 2020·The American Journal of Tropical Medicine and Hygiene·Jean Claude Semuto NgabonzizaLeen Rigouts
Dec 2, 2020·The Journal of Antimicrobial Chemotherapy·Sabira TahseenTom Decroo
Dec 21, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Armand Van Deun, Tom Decroo
Aug 24, 2020·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Pauline LempensBouke C de Jong
Jun 29, 2021·Antimicrobial Agents and Chemotherapy·Jim WerngrenLina Davies Forsman
Jul 2, 2021·Journal of Clinical Tuberculosis and Other Mycobacterial Diseases·Mario C Raviglione, Hans L Rieder
Aug 18, 2021·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Tinne GilsTom Decroo
Jul 13, 2021·Antimicrobial Agents and Chemotherapy·Jacqueline P ErnestVéronique Dartois
Jan 15, 2020·Respiration; International Review of Thoracic Diseases·Neha P MandovraPrashant N Chhajed
Dec 4, 2021·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Qi NieChengfeng Yang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.